Capricor

$4.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.25%) Today
+$0.09 (+2.24%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Capricor and other stocks, options, and ETFs commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps.

CEO
Linda Marbán
Employees
26
Headquarters
Beverly Hills, California
Founded
2005
Market Cap
95.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
215.50K
High Today
$4.16
Low Today
$3.97
Open Price
$4.08
Volume
318.09K
52 Week High
$12.32
52 Week Low
$1.40

CAPR Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 13, After Hours

You May Also Like

ASTE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure